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Medical personnel are often occupationally exposed to chronic ionizing radiation (IR). It is known that IR may have damaging
effects on chromosomes and genes. The aim of this study was to evaluate the genotoxicity of IR on medical personnel using the
micronucleus assay (cytokinesis-block MN) as genotoxicity method and to determine the human health risk. In this study we
observed that medical personnel (with long time of exposer of IR) have a increasing the incidence of micronuclei (MNi) (average
16 MN per 1000 binuclear lymphocites). According to our results we concluded that the micronucleus assay determined that all of
them have a high risk of professional disease and cancer. This study has a practical importance because it indicates the necessity
of introducing a permanent genotoxicological and other type of monitoring of medical personnel exposed to IR and suggests the
need of application of different cytogenetic methods and genotoxicological test (like MN assay) that can confirm the chromosome
rearrangements.
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Introduction
Ionizing radiation (IR) is a type of energy released by
atoms that travel in the form of electromagnetic waves
(gamma or X-rays) or particles (neutrons, beta or alpha)
and that carries enough energy to ionize or remove
electrons from an atom. One form of IR is the excess
energy that is emitted in the spontaneous disintegration
of atoms, process known as radioactivity. There is an
established WHO program for protection of patients and
medical workers against radiation. IR and different
physical and chemical agents can cause major alteration
to the genetic material and other types of chromosomal
instability and damage, or from the genetic point of view,
they have chromosomal mutagenic effect. The
micronucleus assay, as basic genotoxic test in
molecular epidemiology and cytogenetics, is applied as
a diagnostic tool and procedure for measuring
micronucleus (MN) frequency in peripheral blood
lymphocytes (PBL). This assay can be used for
determination of the harmful influence of many of the
damaging agents, as a method to biomonitor human
exposure to genotoxic agents and it can be also used for
detection of a susceptible genetic profile, like presence
and extent of chromosomal damage in human
populations (Fenech et al, 1999). The MN assay in the
last few years is increasingly applied in cultured
lymphocytes, because the possibility of blocking
cytokinesis has made it possible to identify culture cells
that finished one division (second cycle interfase cells).
After the lymphocytes are exposed to a genotoxin, most
of the MNi are forming from previous DNA damaged
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areas, when the the cells are in vitro stimulated to
divide. MNi originate from acentric fragments, whole
chromatids or chromosomes and they are a result of
chromosome breaks or spindle disruption (Kirch-
Volders et al, 1997; 2001; 2003; Fenech, 2000;
Fenech, 2005). Studies have shown that the genotoxic
effects can be reversible when the exposure to IR is
interrupted and also most of the previous studies
concluded that MN frequency were significantly higher
in the exposed subjects compared to the controls
(Sahin, et al., 2009). Comet assay results showed a
significant increase of tail length in workers exposed to
IR. The exposed medical personnel need to carefully
apply radiation protection procedures and minimize, as
low as possible, IR exposure to avoid possible
genotoxic effects (Sakly et al.,2012).
Materials and Methods
The study was approved by the Ethical Committee of
the Faculty of medical sciences in “Goce Delcev”
University in Stip, R. of Macedonia, and all subjects
provided their written consents, according to the
Declaration of Helsinki (2013).
For each individual 1000 binucleated cells were
scored. The number of MN was recorded by criteria
proposed by IAEA (International Atomic Energy
Agency) and Fenech, 2007 The MN score (frequency)
varied from 2 to 36 per 1000 binucleated cells. The
cytokinesis-block MN was used to examine peripheral
blood lymphocytes (PBL) in medical personnel as
radiologist and radiotechnicians, exposed to IR. They
have a different period of exposer (work experince),
age, gender and life style. All subjects were informed
about the aim of the study and they completed a
comprehensive questionnaire about their life style.
Venous blood sample (3 ml) was collected in
heparinized tubes by trained nurses from each
individuals. Fresh blood was collected by venipuncture
and transferred into sterile, heparinized vacutainers.
0.5-ml of blood sample was added to the culture tubes
containing 4.5 ml of RPMI 1640 media enriched with
20% fetal bovine serum, L-glutamine and 0.2 ml of
phytohemagglutinin 1 % and eachsupplemented with
100 units/mL penicillin and 100 µg/mL streptomycin.
The lymphocytes were cultured in 15 mL sterile plastic
tubes with conical bottom (Nunc), the tubes were
mixed gently by invertingfor a few minutes and
incubated (CO2 incubator for 24 hours) for 44h at 37
°C in a slant position. Cytochalasin B was then added
to each culture at a concentration of 3 μg/ml to block
cell cytokinesis and cultures were reincubated at 37 °C
for further 28 h. Cells were then harvested by
centrifugation at 1,000 rpm for 10 min. Supernatant
was discarded by pipetting the media, leaving as little
medium as possible over the cell pellet. Cell pellet was
resuspended in the supernatant remains and 10 ml of
0.56% KCl warm hypotonic solution was added gently
to each tube. Fixation was carried out during 2x15
minutes by fixative (glacial acetic acid: methanol =
1:3). Fixation steps were repeated for three more
times. After that, the fixed lymphocyte cells were
dropped from about 30 cm height using a Pasteur
pipette into microscopic slides. The slides were
stained by 2% alkaline Giemsa for 8 minutes, then
washed in distilled water and examined by light
microscope Leica DM4500 P (×40 and×100). MNi are
defined as small, round nuclei (one (Fig.1) or two
(Fig.2)) clearly separated from the main cell nucleus.
Only cells with clearly visible cytoplasm and
approximately similar-sized nuclei were analyzed.
Fig.1 (binuclear lymphocyte with one micronucleus)
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Fig. 2 (binuclear lymphocyte with two micronucleus)
Results and Discussion
The first (group) of 5 subjects were radiotechnicans,
50-55 years old men with 20-24 years of work
experience on the same work place. One of them, was
receiving a therapy with euthyrox because he had
hypothyroidism. The observed MN frequencies were
compared with the criteria for spontaneous MNi
(4.4±2.6 per 500 BN cells) (Fenech and Morley, 1985).
Results showed that the average  number of MNi in
PBL was 16,4 per 1000 binuclear cells. In according
to this we confirmed the increased MN frequency in
PBL. The secund group (5 subjects) were
radiotechnicans, 40-46 years old men with 10-16
years work experience or exposore on IR. The
average number of MNi in PBL was 14,5 per 1000
binuclear cells. Beside males as subjects in the study
we observe 60 years woman as radiologist, with 30
years of occupational exposure on IR. The results
confirme 19 MNi per 1000 binuclear cells. The time of
exposure is a significant variable that influences the
rate of MNi in lymphocytes. MN frequency in the BN
cells is compatible (or well-matched) biomarker on
mutagen or cytostatic effects of different agents on
human cells (Bonassi et al., 2011; El-zein et al., 2011;
Kocaman et al., 2008). Also, this frequency can
represent an indicator for chromosome damage,
instability and can assess the risk of cancer, acquired
mutations and genetic susceptibility (Fenech, 2000;
Joseph et al., 2009). In according to evaluation of
increased number of MNi in one male (with
hypothyroidism) other study (Al faisal et al., 2012) also
evaluated the evidence of increased MN frequencies
in patients with thyroid disorder, compared to healthy
population. So many factors like age, gender, smoking
etc. can cause MN frequency variation, but gender is
one of the main factors estimated in many studies,
which confirmed that MNi frequencies are higher in
women than in men (Al faisal et al., 2012; Fenech et
al., 1999) generally by 1.2 to 1.6 times (Fenech et al.,
1999). This was explained by over-prevalence of X
chromosome in the female organism (Bolognesi et al.,
2002; catalan et al., 1998). The other possible factor
which increases the number of MN in PBL is smoking
habit. All subjects in the study are long time smokers
(more than 15 years). Some studies (Hando et
al.,1997) confirmed a significant effect of smoking on
MN frequency but other studies (Bonassi et al., 2003;
Hessel et al., 2001; Costa et al., 2006) observed no
relation between smoking habits and MN frequency.
We concluded that all subjects in the study who had
long time of exposure on IR have much more MNi.
These results suggest that chromosomal instability is
in correlation with MNi frequencies. This study has a
practical importance because it indicates the necesety
of introducing a permanent genotoxicological and
other type of monitoring of medical personnel exposed
to IR and suggests the need of application of different
cytogenetic methods and genotoxicological test (like
MN assay) that can confirm the chromosome
rearrangements and risk of cancer.
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